Bone Biologics Corporation (BBLG) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Bone Biologics Corporation (BBLG) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.2M, listed on NASDAQ, employing roughly 2 people, carrying a beta of 0.53 to the broader market. Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Led by Jeffrey Frelick, public since 2021-10-13.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for BBLG as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →